Mitochondrial Complex I Reverses Metabolic Syndrome in Circadian-Disrupted Mice

This groundbreaking study reveals how disrupted sleep-wake cycles contribute to metabolic disease through a previously unknown mechanism involving mitochondrial dysfunction in fat cells.

Researchers studied mice with disrupted circadian clocks and found that mitochondrial complex I—the first enzyme in cellular energy production—loses its normal daily rhythm and becomes impaired. Complex I respiration naturally peaks during active periods and is controlled by BMAL1, a master circadian protein. When this system breaks down, fat cells can't properly process nutrients.

To test whether restoring complex I function could prevent metabolic problems, scientists engineered mice to express NDI1, a yeast enzyme that bypasses damaged complex I. Remarkably, these mice maintained healthy metabolism even on high-fat diets. They showed better glucose tolerance, required less insulin, developed smaller fat cells, and had reduced liver fat—all without losing weight.

The protective effects occurred through improved fat cell remodeling. Instead of enlarging existing fat cells (which promotes inflammation), mice with functional complex I created new, smaller fat cells that remained metabolically healthy. This process maintained proper insulin signaling and reduced inflammatory markers.

These findings suggest that circadian disruption—common in shift workers, frequent travelers, and those with poor sleep—may cause metabolic disease by impairing mitochondrial function in fat tissue. The research opens new therapeutic avenues targeting mitochondrial complex I to treat obesity-related metabolic disorders, potentially offering benefits even without significant weight loss.